GBP0.79
0.38%
London, Jul 11, 05:35 pm CET
ISIN
GB00BL6NGV24
Symbol
DOCS
Industry

Dr Martens Target price 2025 - Analyst rating & recommendation

Dr Martens Classifications & Recommendation:

Buy
50%
Hold
50%

Dr Martens Price Target

Target Price GBP0.83
Price GBP0.79
Potential
Number of Estimates 9
9 Analysts have issued a price target Dr Martens 2026 . The average Dr Martens target price is GBP0.83. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 12 analysts: 6 Analysts recommend Dr Martens to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dr Martens stock has an average upside potential 2026 of . Most analysts recommend the Dr Martens stock at Buy or hold.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Revenue Million GBP 787.60 849.73
10.20% 7.89%
EBITDA Margin 18.08% 20.49%
20.19% 13.33%
Net Margin 0.57% 5.88%
92.76% 929.13%

9 Analysts have issued a sales forecast Dr Martens 2026 . The average Dr Martens sales estimate is

GBP850m
Unlock
. This is
7.89% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
GBP927m 17.67%
Unlock
, the lowest is
GBP776m 1.42%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 GBP788m 10.20%
2026
GBP850m 7.89%
Unlock
2027
GBP899m 5.77%
Unlock
2028
GBP910m 1.30%
Unlock
2029
GBP939m 3.11%
Unlock
2030
GBP986m 5.02%
Unlock
2031
GBP1.0b 4.27%
Unlock
2032
GBP1.1b 4.28%
Unlock

9 Analysts have issued an Dr Martens EBITDA forecast 2026. The average Dr Martens EBITDA estimate is

GBP174m
Unlock
. This is
22.28% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
GBP199m 39.66%
Unlock
, the lowest is
GBP150m 5.60%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 GBP142m 28.33%
2026
GBP174m 22.28%
Unlock
2027
GBP193m 10.91%
Unlock
2028
GBP198m 2.70%
Unlock
2029
GBP207m 4.37%
Unlock

EBITDA Margin

2025 18.08% 20.19%
2026
20.49% 13.33%
Unlock
2027
21.49% 4.88%
Unlock
2028
21.78% 1.35%
Unlock

10 Dr Martens Analysts have issued a net profit forecast 2026. The average Dr Martens net profit estimate is

GBP49.9m
Unlock
. This is
1,009.56% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
GBP56.7m 1,159.33%
Unlock
, the lowest is
GBP42.5m 844.44%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 GBP4.5m 93.50%
2026
GBP49.9m 1,009.56%
Unlock
2027
GBP61.0m 22.13%
Unlock
2028
GBP66.7m 9.35%
Unlock

Net Margin

2025 0.57% 92.76%
2026
5.88% 929.13%
Unlock
2027
6.79% 15.48%
Unlock
2028
7.32% 7.81%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Earnings Per Share GBP 0.00 0.05
100.00%
P/E 15.25
EV/Sales 1.18

Based on analysts' sales estimates for 2026, the Dr Martens stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.28 4.07%
2026
1.18 7.52%
Unlock
2027
1.12 5.46%
Unlock
2028
1.10 1.28%
Unlock
2029
1.07 3.02%
Unlock
2030
1.02 4.79%
Unlock
2031
0.98 4.09%
Unlock
2032
0.94 4.11%
Unlock

P/S ratio

Current 0.97 17.94%
2026
0.89 7.31%
Unlock
2027
0.85 5.46%
Unlock
2028
0.83 1.28%
Unlock
2029
0.81 3.02%
Unlock
2030
0.77 4.79%
Unlock
2031
0.74 4.09%
Unlock
2032
0.71 4.11%
Unlock

Current Dr Martens Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Deutsche
Locked
Locked
Locked Jul 11 2025
RBC Capital Markets
Locked
Locked
Locked May 19 2025
Analyst Rating Date
Locked
Deutsche:
Locked
Locked
Jul 11 2025
Locked
RBC Capital Markets:
Locked
Locked
May 19 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today